Vasodilator responses to ß2-adrenoreceptor agonists are mediated, at least in part, by endothelium-derived nitric oxide (NO) and the use of pulse wave analysis to measure the response to systemic administration of a ß2-agonist has been proposed as a simple means to assess endothelial function (Chowienczyk et al. 1999; Wilkinson et al. 2002). The purpose of the present study was to examine the correlation between the response of the digital volume pulse to the ß2-agonist albuterol and flow mediated NO-dependent, dilation (FMD) of the brachial artery. FMD and pulse wave
responses to albuterol were determined on separate occasions within one
week in 40 healthy subjects (18 women), aged 53 ± 15years . Measurements
were made in a temperature-controlled laboratory in the morning after
an overnight fast and after subjects had rested supine for 30 minutes.
Baseline measurements revealed, systolic blood pressure (132 ±
16 mmHg), diastolic blood pressure (76± 10 mmHg) and total cholesterol
(5.0± 1.0 mmol/l.), means ± SD. FMD was measured using high
resolution ultrasound (HDI 5000, ATL) and automatic wall tracking software
(HDI lab, ATL) and expressed as % dilation of the brachial artery after
reactive hyperaemia (Corretti et al. 2002). Pulse wave analysis (DVP,
Pulse Trace, Micro Medical). The DVP was measured at baseline and during
intravenous infusion of albuterol (5mg/min, for 15 min). The relative
height of the early diastolic peak of the DVP, an index of pressure wave
reflection (RI), was computed from the DVP and the change, from baseline,
( Mean values (±SE)
of FMD and These results suggest that the pulse wave response to albuterol can be used to detect endothelial dysfunction characterised by impaired FMD. Use of ß2 agonist as a probe of endothelial function offers the potential for use in large scale studies. Chowienczyk PJ et
al.( 1999) J Am Coll Cardiol. 34: 2007-2014. |